ArticleFoods (Basel, Switzerland)2025
Urea-Reassembled Soy Lipophilic Protein Nanoparticles for Resveratrol Delivery: Structure, Interfaces, and Digestion.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study investigated the structure, interfacial properties, and digestibility of resveratrol (Res)-loaded soybean lipophilic protein (LP) nanoparticles using a urea-induced disassembly-reassembly approach. Structural analysis confirmed that LP partially restored its secondary to quaternary structures during dialysis, verifying the reversibility of structural reassembly. Analysis of LP-Res nanoparticles showed that increasing urea concentration ([U]) led to the highest encapsulation efficiency (88.32%) and loading capacity (15.91 μg/mg) at 8 M urea. Meanwhile, characterization of interfacial properties indicated that Res-loaded LP-Res nanoparticles improved interfacial features and foam stability, especially under 8U-Res conditions. Furthermore, dynamic in vitro digestion results demonstrated that 8U-Res nanoparticles exhibited sustained release and the highest digestibility (77.8%). These findings reveal the close relationship between LP structural recovery and interfacial functionality, supporting its application as a nanocarrier in nutritional delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.